The more stringent read fraction filters reduce the number of co-infections, but the qPCR filtering also results in a noticable decrease in co-infections (but only affects the FFPE samples).

**A) Effect of Read Fraction Thresholds *without* qPCR Filter**

<table>
  <tbody>
    <tr>
	<th align="center">Read Threshold</th>
	<th align="center">Co-Infection Category</th>
	<th align="center">Archived DNA</th>
	<th align="center">Frozen Tissue</th>
	<th align="center">FFPE Tissue</th>
    </tr>
    <tr>
	<td align="left" rowspan="2">>5% Read Fraction</td>
	<td align="center">2+ HPV Co-Infection</td>
	<td align="center">1 (3.6%)</td>
	<td align="center">2 (5.0%)</td>
	<td align="center">21 (36.8%)</td>
    </tr>
	<td align="center">3+ HPV Co-Infection</td>
	<td align="center">0 (0.0%)</td>
	<td align="center">1 (2.5%)</td>
	<td align="center">12 (21.1%)</td>
    </tr>
    <tr>
	<td align="left" rowspan="2">>20% Read Fraction</td>
	<td align="center">2+ HPV Co-Infection</td>
	<td align="center">1 (3.6%)</td>
	<td align="center">0 (0.0%)</td>
	<td align="center">11 (19.3%)</td>
    </tr>
	<td align="center">3+ HPV Co-Infection</td>
	<td align="center">0 (0.0%)</td>
	<td align="center">0 (0.0%)</td>
	<td align="center">1 (5.3%)</td>
    </tr>
    <tr>
	<td align="left">>50% Read Fraction</td>
	<td align="center">HPV- / Unclear Samples</br>[No Majority Genotype]</td>
	<td align="center">4</br>(14.3%)</td>
	<td align="center">7</br>(17.5%)</td>
	<td align="center">6</br>(10.5%)</td>
    </tr>
</tbody>
</table>

**B) Effect of Read Fraction Thresholds *with* qPCR Filter**

<table>
  <tbody>
    <tr>
	<th align="center">Read Threshold</th>
	<th align="center">Co-Infection Category</th>
	<th align="center">Archived DNA</th>
	<th align="center">Frozen Tissue</th>
	<th align="center">FFPE Tissue</th>
    </tr>
    <tr>
	<td align="left" rowspan="2">>5% Read Fraction</td>
	<td align="center">2+ HPV Co-Infection</td>
	<td align="center">1 (3.6%)</td>
	<td align="center">2 (5.0%)</td>
	<td align="center">10 (23.3%)</td>
    </tr>
	<td align="center">3+ HPV Co-Infection</td>
	<td align="center">0 (0.0%)</td>
	<td align="center">1 (2.5%)</td>
	<td align="center">6 (14.0%)</td>
    </tr>
    <tr>
	<td align="left" rowspan="2">>20% Read Fraction</td>
	<td align="center">2+ HPV Co-Infection</td>
	<td align="center">1 (3.6%)</td>
	<td align="center">0 (0.0%)</td>
	<td align="center">4 (9.3%)</td>
    </tr>
	<td align="center">3+ HPV Co-Infection</td>
	<td align="center">0 (0.0%)</td>
	<td align="center">0 (0.0%)</td>
	<td align="center">1 (2.3%)</td>
    </tr>
    <tr>
	<td align="left">>50% Read Fraction</td>
	<td align="center">HPV- / Unclear Samples</br>[No Majority Genotype]</td>
	<td align="center">4</br>(14.3%)</td>
	<td align="center">7</br>(17.5%)</td>
	<td align="center">1</br>(2.3 %)</td>
    </tr>
</tbody>
</table>

The count of samples with “2+” co-infections is the count of ICC samples with 2 or more co-infections (equal to the number of samples with any co-infections).
